131 related articles for article (PubMed ID: 8863772)
1. Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation.
Omar A; Kempf C; Immelmann A; Rentsch M; Morgenthaler JJ
Transfusion; 1996 Oct; 36(10):866-72. PubMed ID: 8863772
[TBL] [Abstract][Full Text] [Related]
2. Virus inactivation during production of intravenous immunoglobulin.
Kempf C; Jentsch P; Poirier B; Barré-Sinoussi F; Morgenthaler JJ; Morell A; Germann D
Transfusion; 1991 Jun; 31(5):423-7. PubMed ID: 1646503
[TBL] [Abstract][Full Text] [Related]
3. Virus inactivation during intravenous immunoglobulin production.
Hämäläinen E; Suomela H; Ukkonen P
Vox Sang; 1992; 63(1):6-11. PubMed ID: 1329353
[TBL] [Abstract][Full Text] [Related]
4. Potential contribution of mild pepsin treatment at pH4 to the viral safety of human immunoglobulin products.
Reid KG; Cuthbertson B; Jones AD; McIntosh RV
Vox Sang; 1988; 55(2):75-80. PubMed ID: 3142151
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of lipid enveloped viruses by octanoic Acid treatment of immunoglobulin solution.
Dichtelmüller H; Rudnick D; Kloft M
Biologicals; 2002 Jun; 30(2):135-42. PubMed ID: 12127315
[TBL] [Abstract][Full Text] [Related]
6. Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process.
Bos OJ; Sunyé DG; Nieuweboer CE; van Engelenburg FA; Schuitemaker H; Over J
Biologicals; 1998 Dec; 26(4):267-76. PubMed ID: 10403030
[TBL] [Abstract][Full Text] [Related]
7. Assessment of viral inactivation during pH 3.3 pepsin digestion and caprylic acid treatment of antivenoms.
Burnouf T; Terpstra F; Habib G; Seddik S
Biologicals; 2007 Oct; 35(4):329-34. PubMed ID: 17363271
[TBL] [Abstract][Full Text] [Related]
8. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
Korneyeva M; Hotta J; Lebing W; Rosenthal RS; Franks L; Petteway SR
Biologicals; 2002 Jun; 30(2):153-62. PubMed ID: 12127317
[TBL] [Abstract][Full Text] [Related]
9. Comparable virus inactivation by bovine or vegetable derived Tween 80 during solvent/detergent treatment.
Seitz H; Blümel J; Schmidt I; Willkommen H; Löwer J
Biologicals; 2002 Sep; 30(3):197-205. PubMed ID: 12217344
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of viruses by beta-propiolactone in human cryo poor plasma and IgG concentrates.
Scheidler A; Rokos K; Reuter T; Ebermann R; Pauli G
Biologicals; 1998 Jun; 26(2):135-44. PubMed ID: 9811521
[TBL] [Abstract][Full Text] [Related]
11. Low pH, caprylate incubation as a second viral inactivation step in the manufacture of albumin. Parametric and validation studies.
Johnston A; Uren E; Johnstone D; Wu J
Biologicals; 2003 Sep; 31(3):213-21. PubMed ID: 12935811
[TBL] [Abstract][Full Text] [Related]
12. Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb) for viral inactivation.
Azari M; Ebeling A; Baker R; Burhop K; Camacho T; Estep T; Guzder S; Marshall T; Rohn K; Sarajari R
Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):577-82. PubMed ID: 9844723
[TBL] [Abstract][Full Text] [Related]
13. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat.
Borovec S; Broumis C; Adcock W; Fang R; Uren E
Biologicals; 1998 Sep; 26(3):237-44. PubMed ID: 10208725
[TBL] [Abstract][Full Text] [Related]
14. [Inactivation of BVDV (experimental model for hepatitis C) using low pH and heat treatment in intravenous human immunoglobulins].
Ruibal Brunet IJ; Noa Romero E; Rivero Mas AT; Martín García RZ
Sangre (Barc); 1999 Oct; 44(5):352-6. PubMed ID: 10618912
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of human immunodeficiency virus (HIV) by low pH and pepsin.
Kempf C; Jentsch P; Barre-Sinoussi FB; Poirier B; Morgenthaler JJ; Morell A; Germann D
J Acquir Immune Defic Syndr (1988); 1991; 4(8):828-30. PubMed ID: 1856798
[No Abstract] [Full Text] [Related]
16. Inactivation strategy for pseudorabies virus in milk for production of biopharmaceuticals.
Chang JT; Chou YC; Lin MS; Wang SR
Jpn J Vet Res; 2010 Nov; 58(3-4):179-83. PubMed ID: 21180258
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of West-Nile virus during peptic cleavage of horse plasma IgG.
Lazar A; Epstein E; Lustig S; Barnea A; Silberstein L; Reuveny S
Biologicals; 2002 Jun; 30(2):163-5. PubMed ID: 12127318
[TBL] [Abstract][Full Text] [Related]
18. Fusion of enveloped viruses with sperm cells: interaction of Sendai, influenza, and Semliki Forest viruses with bull spermatozoa.
Nussbaum O; Laster J; Loyter A
Exp Cell Res; 1993 May; 206(1):11-5. PubMed ID: 8387018
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of inactivation of viral contaminants in hyperimmune horse plasma against botulinum toxin by low pH alone and combined with pepsin digestion.
Torgeman A; Mador N; Dorozko M; Lifshitz A; Eschar N; White MD; Wolf DG; Epstein E
Biologicals; 2017 Jul; 48():24-27. PubMed ID: 28633975
[TBL] [Abstract][Full Text] [Related]
20. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.
Lin L; Cook DN; Wiesehahn GP; Alfonso R; Behrman B; Cimino GD; Corten L; Damonte PB; Dikeman R; Dupuis K; Fang YM; Hanson CV; Hearst JE; Lin CY; Londe HF; Metchette K; Nerio AT; Pu JT; Reames AA; Rheinschmidt M; Tessman J; Isaacs ST; Wollowitz S; Corash L
Transfusion; 1997 Apr; 37(4):423-35. PubMed ID: 9111281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
